The Carlyle Group
http://www.carlyle.com/The Carlyle Group is one of the world’s largest private equity firms. The firm has more than $81.1 billion under management with 60 funds across four investment disciplines: buyouts, venture & growth capital, real estate and leveraged finance. Carlyle focuses on sectors including: aerospace & defense, automotive & transportation, consumer & retail, energy & power, financial services, healthcare, industrial, infrastructure, real estate, technology & business services and telecommunications & media. Carlyle employs more than 575 investment professionals, and its portfolio companies employ more than 286,000 people worldwide. The firm is based in Washington DC and has over 1200 investors in 68 countries.
View Older Stories View More Recent Stories
-
Involta Expands Its Cleveland Market Data Center
-
Tessera Therapeutics Expands Leadership and Board
-
Olympus nearing deal to sell microscope unit for over $2 billion - sources
-
Hilb Group Names Darren Cohen Carrier Relations and Insurance Strategy Leader; Builds on Focus to Strengthen Offerings for Clients and Agency Partners
-
S.Korean EV battery maker SK On raises $1.5 billion in expansion push -report
-
U.S. on track to break record for the most products recalled in a single year
-
Piramal Critical Care Launches First to Market Generic Zinc Sulfate Injection in the U.S.
-
Involta Appoints Data Center Industry Leader to Its Board of Directors
-
Abrigo expands lending automation with acquisition of BankLabs' Construct and +Pay technologies
-
Form 13F-HR Carlyle Group Inc. For: Jun 30
-
Analysis: How Carlyle CEO Kewsong Lee's turnaround of the private equity firm was cut short
-
Form SC 13D/A EXICURE, INC. Filed by: Carlyle Group Inc.
-
Form SC 13D/A Vera Therapeutics, Inc. Filed by: Carlyle Group Inc.
-
Form SC 13D/A Adicet Bio, Inc. Filed by: Carlyle Group Inc.
-
Form SC 13D/A NuCana plc Filed by: Carlyle Group Inc.
-
Form SC 13D/A eFFECTOR Therapeutics, Filed by: Carlyle Group Inc.
-
Form SC 13D/A SOLENO THERAPEUTICS INC Filed by: Carlyle Group Inc.
-
Form SC 13D/A Reneo Pharmaceuticals, Filed by: Carlyle Group Inc.
-
Form SC 13D/A SPRUCE BIOSCIENCES, INC. Filed by: Carlyle Group Inc.
-
Form SC 13D/A Jasper Therapeutics, Filed by: Carlyle Group Inc.
-
Sciens Building Solutions Finalizes San Antonio Acquisition
-
Form 4 ZoomInfo Technologies For: Aug 05 Filed by: Carlyle Group Inc.
-
Carlyle Secured Lending, Inc. Announces Second Quarter 2022 Financial Results and Increases Quarterly Base Dividend Rate
-
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Board Appointment, Changes
-
Hilb Group Acquires Massachusetts-based Lighthouse Insurance Agency, Expands Transportation Specialty in New England
-
TPG quarterly earnings more than triple on fee growth, asset sales
-
InMed Pharmaceuticals Inc. (INM) Appoints Nicole Lemerond to its Board
-
InMed Announces Changes to its Board of Directors
-
InMed Announces Changes to its Board of Directors
-
Hilb Group Acquires New England-based Business, Expands Market Presence
-
Bridge Investment Group Holdings (BRDG) Appoints Jeremy Ford as Chief Investment Officer
-
Bridge Investment Group Announces Expansion Into PropTech, Hires Jeremy Ford as Chief Investment Officer
-
WHITE MOUNTAINS REPORTS SECOND QUARTER RESULTS
-
Form 8-K Carlyle Group Inc. For: Aug 07
-
The Carlyle Group (CG) Announces Upcoming CEO Transition
-
Carlyle CEO Kewsong Lee steps down in abrupt early departure
-
CARLYLE ANNOUNCES SENIOR LEADERSHIP CHANGES
-
Apollo's Q2 earnings rise as Athene helps brave dealmaking slowdown
-
Form 4 Carlyle Group Inc. For: Aug 01 Filed by: Ferguson Jeffrey W.
-
Form 4 Carlyle Group Inc. For: Aug 01 Filed by: Buser Curtis L.
-
Form 4 Carlyle Group Inc. For: Aug 01 Filed by: Larson Bruce M.
-
Form 4 Carlyle Group Inc. For: Aug 01 Filed by: Finn Christopher
-
Form 4 Carlyle Group Inc. For: Aug 01 Filed by: Andrews Charles Elliott Jr.
-
Sigma7 Appoints Jennifer Gold as Chief Technology Officer
-
KKR profit falls 9% on lower deal fees
-
Form 424B3 Carlyle Group Inc.
-
Form 8-K Carlyle Group Inc. For: Aug 01
-
disguise Wins an Emmy Award for its Extended Reality Solution
-
UPDATE: Evercore ISI Upgrades The Carlyle Group LP (CG) to Outperform
-
Form 10-Q Carlyle Group Inc. For: Jun 30

